SRL
IMCR icon

Scientech Research LLC’s Immunocore IMCR Stock Holding History

Scientech Research LLC’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
+8,854
New +$262K 0.23% 119

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Scientech Research LLC's IMCR Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Immunocore (IMCR) in Q2 2026: 8,854 shares worth $281K. The stake represents 0.23% of the portfolio and ranks #119 among its holdings.

136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Scientech Research LLC held 8,854 shares of Immunocore worth $281K as of Q2 2026.
  • Immunocore was a new Scientech Research LLC position in Q2 2026.
  • Immunocore made up 0.23% of Scientech Research LLC's portfolio in Q2 2026, its #119 holding.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.